Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01608308 · ClinicalTrials.gov registry record · NA

Intraoperative and Post-operative Analgesic Effect of IV Acetaminophen for Sinus Surgery

A NA study of Chronic Sinusitis, sponsored by The University of Texas Health Science Center, Houston.

Completed
Registry status
NA
Development phase
62
Enrollment target
1
Study location

NCT01608308: Completed NA study of Chronic Sinusitis, sponsored by The University of Texas Health Science Center, Houston.

NCT01608308 is a NA study of Chronic Sinusitis that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 62 participants, below the 189-participant average among 9 other Chronic Sinusitis trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01608308, a NA study of Chronic Sinusitis, has completed, sponsored by The University of Texas Health Science Center, Houston.

COMPLETED
Registry status
NA
Development phase
62 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to assess the use of IV acetaminophen (Ofirmev) as a and safe and efficacious agent in reducing post-operative pain; we hypothesize that its use will reduce post-operative pain when compared to a control group using the visual analogue score (VAS) analog pain scoring system.

Primary Outcome

VAS is a validated, self-reported data sheet assessing average pain intensity. Possible scores range from 0 (no pain) to 10 (highest level of pain).

Conditions Studied

Interventions

  • DRUG Placebo
  • DRUG IV Acetaminophen

Study Locations (1)

Texas

  • The University of Texas Health Sciences Center at Houston - Houston

Trial Details

FieldValue
Enrollment Target 62 participants
Start Date 2012-07
Est. Completion 2014-09
Phase NA

What the finished NCT01608308 record still lists

NCT01608308 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 62 participants, a relatively small participant target, below the 189-participant average among 9 other Chronic Sinusitis trials with a reported enrollment target (67% lower).

The record links to 1 condition, with Chronic Sinusitis appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT01608308 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT01608308 about?

NCT01608308 is a clinical study titled "Intraoperative and Post-operative Analgesic Effect of IV Acetaminophen for Sinus Surgery". The purpose of this study is to assess the use of IV acetaminophen (Ofirmev) as a and safe and efficacious agent in reducing post-operative pain; we hypothesize that its use will reduce post-operative pain when compared to a control group using the visual analogue score (VAS) analog pain scoring sys...

What is the current status of trial NCT01608308?

This trial is currently completed. It is a NA study. The enrollment target is 62 participants. The study started on 2012-07. Estimated completion is 2014-09.

What conditions does trial NCT01608308 study?

This clinical trial studies the following conditions: Chronic Sinusitis.

What interventions are being tested in trial NCT01608308?

The interventions under investigation include: Placebo (DRUG), IV Acetaminophen (DRUG).

Who is sponsoring clinical trial NCT01608308?

This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01608308 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Sinusitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01608308's enrollment target sits among peer trials

62 4th of 9 higher than 6 of 9 other Chronic Sinusitis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Chronic Sinusitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03231150 · 62 participants · NA

    Plantar Fasciitis Randomized Clinical Control Trial

  • NCT03458676 · 62 participants · NA

    Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies

  • NCT03596086 · 62 participants · Phase 1

    HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM

  • NCT03603405 · 62 participants · Phase 1

    HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01608308, the US trial registry maintained by the National Library of Medicine. NCT01608308 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.